{
  "@context": "https://schema.org/",
  "@type": "Dataset",
  "id": "immune:quercetin-infl-inf05:inflammation:v1",
  "title": "Quercetin â€” Inflammation",
  "category": "inflammation",
  "tier": "Black",
  "label": "FAIL",
  "P_effect_gt_delta": 0.0,
  "gate_results": {
    "phi": "PASS",
    "r": 0.824,
    "j": 0.574,
    "k": "PASS",
    "l": "PASS"
  },
  "evidence_summary": {
    "n_studies": 3,
    "total_n": 497,
    "I2": 0.0,
    "tau2": 0.00028586,
    "mu_hat": -0.3494,
    "mu_CI95": [
      -0.4976,
      -0.2012
    ],
    "design_breakdown": {
      "RCT": 3,
      "cohort": 0,
      "other": 0
    }
  },
  "policy_refs": {
    "tel5_levels": "v1.2.0",
    "monte_carlo": "v1.0.1-reml-grid",
    "journal_trust": "2025-10-05"
  },
  "version": "v1",
  "policy_fingerprint": "0xbe3a798944b1c64b",
  "tier_label_system": "TEL-5",
  "created": "2025-10-27T01:51:32.536960+00:00",
  "preferred_citation": "Kim G. TERVYX Protocol v1.0 (2025).",
  "bibtex": "@techreport{tervyx2025, title={TERVYX Protocol v1.0}, author={Kim, Geonyeob}, year={2025}}",
  "csl_json": {
    "type": "report",
    "title": "TERVYX Protocol v1.0",
    "author": [
      {
        "family": "Kim",
        "given": "Geonyeob"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2025
        ]
      ]
    }
  },
  "references": [
    {
      "@id": "doi:10.1234/infl-inf05-01",
      "@type": "ScholarlyArticle",
      "identifier": "doi:10.1234/infl-inf05-01",
      "studyIds": [
        "INFL-INF05-01"
      ],
      "citation": "INFL-INF05-01 (2012); Journal: inflammation-journal-01; Design: randomized controlled trial; Population: Adults with skin inflammation concerns; Outcome: skin_inflammation; DOI: 10.1234/infl-inf05-01; Adverse Events: Mild GI discomfort.",
      "doi": "10.1234/infl-inf05-01",
      "sameAs": "https://doi.org/10.1234/infl-inf05-01",
      "datePublished": "2012",
      "isPartOf": {
        "@type": "Periodical",
        "name": "inflammation-journal-01"
      }
    },
    {
      "@id": "doi:10.1234/infl-inf05-02",
      "@type": "ScholarlyArticle",
      "identifier": "doi:10.1234/infl-inf05-02",
      "studyIds": [
        "INFL-INF05-02"
      ],
      "citation": "INFL-INF05-02 (2017); Journal: inflammation-journal-02; Design: randomized controlled trial; Population: Adults with skin inflammation concerns; Outcome: skin_inflammation; DOI: 10.1234/infl-inf05-02; Adverse Events: None reported.",
      "doi": "10.1234/infl-inf05-02",
      "sameAs": "https://doi.org/10.1234/infl-inf05-02",
      "datePublished": "2017",
      "isPartOf": {
        "@type": "Periodical",
        "name": "inflammation-journal-02"
      }
    },
    {
      "@id": "doi:10.1234/infl-inf05-03",
      "@type": "ScholarlyArticle",
      "identifier": "doi:10.1234/infl-inf05-03",
      "studyIds": [
        "INFL-INF05-03"
      ],
      "citation": "INFL-INF05-03 (2022); Journal: inflammation-journal-03; Design: randomized controlled trial; Population: Adults with skin inflammation concerns; Outcome: skin_inflammation; DOI: 10.1234/infl-inf05-03; Adverse Events: Transient headache.",
      "doi": "10.1234/infl-inf05-03",
      "sameAs": "https://doi.org/10.1234/infl-inf05-03",
      "datePublished": "2022",
      "isPartOf": {
        "@type": "Periodical",
        "name": "inflammation-journal-03"
      }
    }
  ],
  "citations_manifest_hash": "sha256:72374f0055ab0d9a7f6471caa518b87fa0593721b5fa351434a4883591557753",
  "audit_hash": "0x50fd0ed4d536d447"
}
